Cancer remains one of the leading causes of mortality worldwide, creating an urgent demand for innovative and affordable oncology medicines. Eribulin Mesylate 0.5mg/ml Injection has emerged as a breakthrough chemotherapy medication for patients battling advanced stages of breast cancer and liposarcoma.
Cordium Pharmaceuticals Pvt Ltd, an India-based pharmaceutical exporter, is committed to supplying high-quality oncology medicines to healthcare institutions, distributors, hospitals, and government procurement agencies worldwide.
What is Eribulin Mesylate 0.5mg/ml Injection?
Eribulin Mesylate Injection is an anti-cancer chemotherapy medicine primarily indicated for:
Advanced or metastatic breast cancer
Unresectable or metastatic liposarcoma
Patients previously treated with anthracycline and taxane therapies
It belongs to the microtubule dynamics inhibitor class, helping stop cancer cell growth and preventing tumor progression.
Therapeutic Uses of Eribulin Mesylate Injection
1. Metastatic Breast Cancer Treatment
Eribulin is prescribed for patients whose breast cancer has spread to other organs after previous chemotherapy treatments have failed.
2. Advanced Liposarcoma Management
It significantly improves overall survival in patients with advanced soft tissue sarcoma, especially liposarcoma.
3. Third-Line Cancer Therapy
Oncologists frequently recommend Eribulin when standard chemotherapy options no longer provide desired outcomes.
How Does Eribulin Mesylate Work?
Eribulin inhibits the growth and division of cancer cells by targeting microtubules during cell replication.
Mechanism of Action:
Prevents cancer cell multiplication
Interrupts mitosis (cell division)
Reduces tumor growth
Delays disease progression
Improves patient survival rates
Dosage & Administration
Strength: Eribulin Mesylate 0.5mg/ml Injection
Route: Intravenous (IV) administration
Administration: Only under supervision of qualified oncology specialists.
Dosage Schedule: Determined by the physician based on:
Patient body surface area
Cancer stage
Previous chemotherapy exposure
Kidney and liver function
Note: Always follow medical advice. Self-medication is strictly prohibited.
Common Side Effects
Patients may experience:
Fatigue
Hair loss (alopecia)
Nausea
Constipation
Peripheral neuropathy
Low white blood cell count (neutropenia)
Fever
Weakness
Seek immediate medical attention if severe symptoms occur.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is a trusted Indian pharmaceutical exporter specializing in oncology medicines.
Our Export Advantages
✅ WHO-GMP compliant manufacturing partners
✅ International quality standards
✅ Global regulatory documentation support
✅ Reliable cold chain logistics
✅ Competitive pricing
✅ Bulk order supply capability
✅ Third-party manufacturing support
✅ Private labeling opportunities
Countries We Export Eribulin Mesylate 0.5mg/ml Injection To
Africa
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇿🇦 South Africa
Asia
🇵🇭 Philippines
🇻🇳 Vietnam
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
Middle East
🇦🇪 UAE
🇸🇦 Saudi Arabia
Western Markets
🇺🇸 USA
🇬🇧 UK
We collaborate with:
Oncology hospitals
Pharmaceutical distributors
Government tenders
Importers
Cancer treatment centers
Healthcare procurement agencies
Growing Demand for Eribulin Mesylate in Global Markets
Several countries are experiencing increased demand for affordable oncology medications due to:
Kenya
Increasing investment in cancer treatment infrastructure.
Nigeria
Rising breast cancer prevalence and expanding oncology centers.
Ghana
Government initiatives improving cancer care access.
Philippines
Growing adoption of advanced chemotherapy treatments.
Vietnam
Rapidly expanding oncology healthcare sector.
UAE & Saudi Arabia
Strong demand for premium oncology imports.
Uzbekistan & Kazakhstan
Healthcare modernization and increased cancer screening programs.
USA & UK
Need for reliable pharmaceutical supply chain partnerships.
South Africa
Expanding access to affordable cancer therapies.
About Cordium Pharmaceuticals Pvt Ltd
Cordium Pharmaceuticals Pvt Ltd is dedicated to delivering affordable, quality-driven pharmaceutical solutions globally.
We support international partners through:
Regulatory assistance
Export documentation
Fast global shipping
Distributor partnerships
Long-term supply agreements
Looking for a Reliable Eribulin Mesylate 0.5mg/ml Injection Exporter?
Partner with Cordium Pharmaceuticals Pvt Ltd for premium-quality oncology medicines and dependable global pharmaceutical exports.
Serving: Kenya | Nigeria | Ghana | Philippines | Vietnam | UAE | Saudi Arabia | Uzbekistan | Kazakhstan | USA | UK | South Africa
Cordium Pharmaceuticals Pvt Ltd, an India-based pharmaceutical exporter, is committed to supplying high-quality oncology medicines to healthcare institutions, distributors, hospitals, and government procurement agencies worldwide.
What is Eribulin Mesylate 0.5mg/ml Injection?
Eribulin Mesylate Injection is an anti-cancer chemotherapy medicine primarily indicated for:
Advanced or metastatic breast cancer
Unresectable or metastatic liposarcoma
Patients previously treated with anthracycline and taxane therapies
It belongs to the microtubule dynamics inhibitor class, helping stop cancer cell growth and preventing tumor progression.
Therapeutic Uses of Eribulin Mesylate Injection
1. Metastatic Breast Cancer Treatment
Eribulin is prescribed for patients whose breast cancer has spread to other organs after previous chemotherapy treatments have failed.
2. Advanced Liposarcoma Management
It significantly improves overall survival in patients with advanced soft tissue sarcoma, especially liposarcoma.
3. Third-Line Cancer Therapy
Oncologists frequently recommend Eribulin when standard chemotherapy options no longer provide desired outcomes.
How Does Eribulin Mesylate Work?
Eribulin inhibits the growth and division of cancer cells by targeting microtubules during cell replication.
Mechanism of Action:
Prevents cancer cell multiplication
Interrupts mitosis (cell division)
Reduces tumor growth
Delays disease progression
Improves patient survival rates
Dosage & Administration
Strength: Eribulin Mesylate 0.5mg/ml Injection
Route: Intravenous (IV) administration
Administration: Only under supervision of qualified oncology specialists.
Dosage Schedule: Determined by the physician based on:
Patient body surface area
Cancer stage
Previous chemotherapy exposure
Kidney and liver function
Note: Always follow medical advice. Self-medication is strictly prohibited.
Common Side Effects
Patients may experience:
Fatigue
Hair loss (alopecia)
Nausea
Constipation
Peripheral neuropathy
Low white blood cell count (neutropenia)
Fever
Weakness
Seek immediate medical attention if severe symptoms occur.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is a trusted Indian pharmaceutical exporter specializing in oncology medicines.
Our Export Advantages
✅ WHO-GMP compliant manufacturing partners
✅ International quality standards
✅ Global regulatory documentation support
✅ Reliable cold chain logistics
✅ Competitive pricing
✅ Bulk order supply capability
✅ Third-party manufacturing support
✅ Private labeling opportunities
Countries We Export Eribulin Mesylate 0.5mg/ml Injection To
Africa
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇿🇦 South Africa
Asia
🇵🇭 Philippines
🇻🇳 Vietnam
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
Middle East
🇦🇪 UAE
🇸🇦 Saudi Arabia
Western Markets
🇺🇸 USA
🇬🇧 UK
We collaborate with:
Oncology hospitals
Pharmaceutical distributors
Government tenders
Importers
Cancer treatment centers
Healthcare procurement agencies
Growing Demand for Eribulin Mesylate in Global Markets
Several countries are experiencing increased demand for affordable oncology medications due to:
Kenya
Increasing investment in cancer treatment infrastructure.
Nigeria
Rising breast cancer prevalence and expanding oncology centers.
Ghana
Government initiatives improving cancer care access.
Philippines
Growing adoption of advanced chemotherapy treatments.
Vietnam
Rapidly expanding oncology healthcare sector.
UAE & Saudi Arabia
Strong demand for premium oncology imports.
Uzbekistan & Kazakhstan
Healthcare modernization and increased cancer screening programs.
USA & UK
Need for reliable pharmaceutical supply chain partnerships.
South Africa
Expanding access to affordable cancer therapies.
About Cordium Pharmaceuticals Pvt Ltd
Cordium Pharmaceuticals Pvt Ltd is dedicated to delivering affordable, quality-driven pharmaceutical solutions globally.
We support international partners through:
Regulatory assistance
Export documentation
Fast global shipping
Distributor partnerships
Long-term supply agreements
Looking for a Reliable Eribulin Mesylate 0.5mg/ml Injection Exporter?
Partner with Cordium Pharmaceuticals Pvt Ltd for premium-quality oncology medicines and dependable global pharmaceutical exports.
Serving: Kenya | Nigeria | Ghana | Philippines | Vietnam | UAE | Saudi Arabia | Uzbekistan | Kazakhstan | USA | UK | South Africa
Keywords
